All Episodes

August 25, 2022 56 mins
In this episode, our host Dr. Swikrity U Baskota (@baskotacytopath), founder of www.matchtopath.com discusses the Electronic Residency Application Service® (ERAS®) pathology residency process with our expert panelists. The speakers include Dr. Thomas Cummings (@tjcmd888) Professor of Pathology, Director of Neuropathology and Ophthalmic Pathology and Residency Program Director at Duke University, North Carolina,  Dr. Carlos Pagan (@CAPaganPath) Assistant Professor of Surgical and Molecular Pathology and Residency Program Director at Columbia University, Dr. Clarissa Jordan (@pathcejmd), PGY-3 resident at Mayo Clinic, Future hematopathology fellow at Mayo Clinic and Dr. Melissa Meija Bautista (@Melissa_MB91), PGY-4 resident at Northwestern University, Future Pediatric pathology Fellow at Boston Children’s Hospital and future neuropathology fellow at Northwestern University, Chicago. 

 

Join us to learn more about the 2023 ERAS application timeline. What is a program looking for in a candidate’s application? How can you strengthen your ERAS CV, and personal statement? How can you ensure your application is ready before the deadline...and many other tips shared by our expert guests!

  

Reference:

ERAS® 2023 Residency Timeline | Students & Residents (aamc.org)

 

MatchtoPath: www.matchtopath.com

Twitter: @matchtopath;  Instagram, Facebook and LinkedIn: matchtopath 

 

Mark as Played

Advertise With Us

Popular Podcasts

Dateline NBC
The Nikki Glaser Podcast

The Nikki Glaser Podcast

Every week comedian and infamous roaster Nikki Glaser provides a fun, fast-paced, and brutally honest look into current pop-culture and her own personal life.

Stuff You Should Know

Stuff You Should Know

If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2024 iHeartMedia, Inc.